Teva
Teva settles ‘pay-to-delay’ case with FTC
February 21, 2019Business Services, Sales and Marketing FTC, Teva, antitrust, drugs, generics, monopoly
Teva Pharmaceuticals has settled a dispute with the Federal Trade Commission (FTC) over three separate federal court antitrust lawsuits involving …
Top Ten most popular articles on Pharmafile.com this week!
December 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Eli Lilly, Novartis, Teva, Tilray, brexit, celltrion, pharma, top 10
Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …
Celltrion and Teva’s Herceptin biosimilar secures FDA approval in breast cancer
December 18, 2018Manufacturing and Production, Sales and Marketing Herceptin, Herzuma, Teva, celltrion, pharma
Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by …
Generics firms investigated for their involvement in the ‘largest cartel in the history of the United States’
December 11, 2018Manufacturing and Production Dr Reddy's, Mylan, Teva, US, corruption, generics, price fixing, price-fixing, sun
At least 16 generic drugmakers are being investigated for their involvement in what has been described as the “largest cartel …
FDA approves first Rituxan biosimilar courtesy of Teva and Celltrion
November 29, 2018Sales and Marketing FDA, Genentech, Rituxan, Roche, Teva, Truxima, biosimilars, celltrion
The FDA has announced the first US approval of a biosimilar version of Genentech’s Rituxan (rituximab), awarding marketing approval to …
Teva’s EpiPen generic retails for same price as Mylan’s own
November 28, 2018Research and Development, Sales and Marketing Mylan, Teva, epipen, pharma
Israeli generics firm Teva has revealed the price tag of its generic version of Mylan’s EpiPen epinephrine auto-injector, and, at …
FDA greenlights Teva’s migraine drug Ajovy in two dosage options
September 20, 2018Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma
Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …
Teva shares soar after migraine treatment Ajovy approval
September 17, 2018Sales and Marketing FDA, Teva, US, ajovy, approval, israel
Shares in the Israeli pharma firm Teva soared on Sunday after the announcement that the US Food and Drug Administration …
Teva names new President, TAPI and Biologics Operations
September 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Novartis, Teva, appointment
Israeli generic drug specialist Teva has announced its appointment of John Nason in a multi-faceted role as President of Teva …
Teva drops MS and Huntington’s disease drug laquinimod, leaving rights to Active Biotech
September 6, 2018Medical Communications, Research and Development Active Biotech, Laquinimod, Teva, pharma
Israeli multinational Teva Pharmaceutical has decided to discontinue the development of laquinimod. As such, all rights for the orally administered …
FDA approves first-ever generic EpiPen versions, courtesy of Teva
August 17, 2018Medical Communications, Sales and Marketing FDA, Mylan, Teva, US, epipen, pharma
The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as …
Teva to relocate US HQ to New Jersey, affecting over 1,000 jobs
July 6, 2018Manufacturing and Production, Medical Communications Teva, US, new jersey, pharma, philadelphia
As the Israeli firm presses on with attempts to cut back on costs and streamline operations, Teva has announced plans …
Teva axes Phase 3 trial into chronic cluster headache
June 18, 2018Research and Development, Sales and Marketing Teva, fremanezumab, headache, pharma
With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate …
New Jersey attempts to lure Teva HQ with tax incentives
June 15, 2018Medical Communications Teva, biotech, drugs, pharma, pharmaceutical
Teva has been doing some major global restructuring since Kare Schultz came to the helm of the embattled, Israeli drugmaker. …
Axovant snatches Teva and Allergan execs to strengthen management
June 5, 2018Manufacturing and Production, Medical Communications Allergan, Axovant, Teva, appointment, pharma
Axovant has announced reinforcements to its management team with two new additions, snatching up Allergan’s current Chief Medical Officer Dr …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
AI: an early warning system for patient safety
Highlighting the value of lab research for healthcare innovation
